Abstract
Background Urinary tract infections (UTIs) are a leading cause of hospitalization in people living with dementia, making accurate detection and prompt treatment critical in this vulnerable population.
Methods This retrospective, longitudinal cohort study evaluated the diagnostic accuracy of self-reported symptoms and urine dipstick test results for identifying UTIs in people with dementia. Participants included 78 community-dwelling individuals over the age of 50 with a confirmed dementia diagnosis. These participants were recruited from cohorts established by the Surrey and Borders Partnership NHS Foundation Trust and the Hammersmith & Fulham Partnership Primary Care Network between late 2019 and 2023.
Results The frequency of UTIs in people living with dementia (PLWD) is highly variable, some individuals having nearly chronic infections and others not acquiring a single UTI during their enrolment in the study. The taxonomy of the microbes associated with the urinary tract infections in this cohort were consistent with those that have been observed in other demographics. When we modelled the relationship between self-reported symptoms, dipstick results, and the presence of UTIs we found that there was no significant relationship between UTI and symptoms. However, there was a highly significant correlation between dipstick test results positive for leucocytes and nitrites with the presence of a UTI.
Conclusions Urine dipstick tests for nitrites and leucocytes should be incorporated into diagnostic protocols and should also be considered for ongoing surveillance of UTIs in people living with dementia.
Study Registration Numbers Research Ethics Committee (REC) reference: 19/LO/0102
Integrated Research Application System (IRAS) project ID: 257561
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by the UK Dementia Research Institute which receives its funding from UK DRI Ltd funded by the UK Medical Research Council, Alzheimers Society, and Alzheimers Research UK.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The London-Surrey Borders Research Ethics Committee gave ethical approval for this work (REC: 19/LO/0102) The study is registered with National Institute for Health and Care Research (NIHR) in the United Kingdom under Integrated Research Application System (IRAS) registration number 257561.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data used in the present work are available upon reasonable request to the authors.
Log in using your username and password
Log in through your institution
